Filing Flows › Foxo Technologies (FOXO) › Q1 2026 › vs Q1 2025
Foxo Technologies (FOXO) Q1 2026 vs Q1 2025 (year over year)
Foxo Technologies's revenue rose $2.0M (+63%) from $3.2M in Q1 2025 to $5.2M in Q1 2026. The biggest changes: HealthCares +$1.6M (+52%); Labs −$4K (-48%).
Foxo Technologies, Q1 2026: revenue $5.2M (+63% year over year), operating margin -5.4%, net loss $1.5M, operating cash flow −$578K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| HealthCares | $4.8M | $3.2M | $1.6M | +52% |
| Labs | $4K | $8K | −$4K | -48% |
| Revenue | $5.2M | $3.2M | $2.0M | +63% |
| Net loss | $1.5M | $621K | $834K | +134% |
| Costs & expenses | $6.6M | $4.7M | $1.9M | +40% |
| Operating costs | $5.4M | $4.7M | $728K | +15% |
| Interest & other, net | $1.2M | −$926K | $2.1M | — |
| Research & development | $36K | $30K | $6K | +19% |
| SG&A | $2.9M | $2.8M | $111K | +4% |
| Other operating costs | $2.5M | $1.9M | $611K | +32% |
| Operating cash sources | $1.5M | $593K | $862K | +145% |
| Depreciation & amortization | $171K | $143K | $28K | +20% |
| Working capital & other | $706K | −$888K | $1.6M | — |
| Cash used in operations | $578K | $1.3M | −$760K | -57% |
| Net loss absorbed | $1.5M | $621K | $834K | +134% |
Questions
How much did Foxo Technologies's revenue grow year over year in Q1 2026?
Foxo Technologies's revenue rose $2.0M (+63%) from $3.2M in Q1 2025 to $5.2M in Q1 2026.
What drove Foxo Technologies's revenue change in Q1 2026?
HealthCares +$1.6M (+52%); Labs −$4K (-48%).